Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in China
Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study
Where
Harbin
Age
18 years to 99 years
People
47
Run by
The Third Affiliated Hospital of Harbin Medical University
See details and how to joinNCT07398560
Phase 2Taking people
Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC
Where
Shanghai
Age
18 years to 75 years
People
116
Run by
Fudan University
See details and how to joinNCT07398937
No phaseTaking people
Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics
Where
Shanghai
Age
18 years and over
People
240
Run by
Baohui Han
See details and how to joinNCT07399210
Phase 2Taking people
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
Where
Sichuan
Age
18 years to 75 years
People
202
Run by
Sichuan University
See details and how to joinNCT06610734
No phaseTaking people
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Foshan, Fuzhou, Guangzhou, Harbin, Hefei, Kunming, Meizhou, Nanchang, Nanjing, Nanning, Qingdao, Shenyang, Shenzhen, Taiyuan, Tianjin, Wuhan, Xiamen, Yangzhou, Zhenzhou
Age
18 years and over
People
800
Run by
Alpha Biopharma (Jiangsu) Co., Ltd.
See details and how to joinNCT07143045
No phaseTaking people
Functional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm Clinical Study
Where
Chongqing
Age
18 years to 85 years
People
100
Run by
The Second Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07339644
No phaseNot yet taking people in China
Non-intubated Versus Intubated Anesthesia for Thoracoscopic Sublobar Resection
Where
Guangzhou
Age
18 years to 80 years
People
1,600
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07395375
Phase 1Taking people
A Study of SH009 Injection in Patients With Advanced Solid Tumors.
Where
Shanghai
Age
18 years and over
People
150
Run by
Nanjing Sanhome Pharmaceutical, Co., Ltd.
See details and how to joinNCT07390838
Phase 2Not yet taking people in China
Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone
Where
Beijing
Age
18 years to 75 years
People
76
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07381543
Phase 3Not yet taking people in China
Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
500
Run by
Shanghai Huaota Biopharmaceutical Co., Ltd.
See details and how to joinNCT07383116
Phase 1Taking people
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer
Where
Guangzhou
Age
18 years to 75 years
People
328
Run by
HC Biopharma Inc.
See details and how to joinNCT07381829
Phase 2Taking people
Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.
Where
Huizhou
Age
18 years to 75 years
People
36
Run by
Guangzhou Medical University
See details and how to joinNCT06296745
No phaseEnrolling by invitation
Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis
Where
Beijing
Age
18 years and over
People
380
Run by
Ming Yang
See details and how to joinNCT07373951
No phaseTaking people
Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib
Where
Shenzhen
Age
18 years and over
People
20
Run by
Peking University Shenzhen Hospital
See details and how to joinNCT07374614
No phaseNot yet taking people in China
A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational Study
Where
Changchun, Kunming, Shanghai, Shenyang, Shijiazhuang, Zhengzhou
Age
40 years to 74 years
People
14,300
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07375979
Phase 1Taking people
A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
Where
Shanghai
Age
18 years and over
People
194
Run by
Hefei TG ImmunoPharma Co., Ltd.
See details and how to joinNCT07376707
Phase 2Enrolling by invitation
the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib
Where
Zhengzhou
Age
18 years and over
People
41
Run by
Henan Cancer Hospital
See details and how to joinNCT06370416
Phase 4Taking people
Effects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted Thoracoscopic Surgery
Where
Wuhan
Age
40 years to 80 years
People
1,058
Run by
Tongji Hospital
See details and how to joinNCT07028593
Phase 1/2Taking people
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Where
Beijing, Hangzhou, Zhengzhou
Age
18 years and over
People
266
Run by
Beijing Tide Pharmaceutical Co., Ltd
See details and how to joinNCT07371663
Phase 2Taking people
A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)
Where
Shenyang
Age
18 years to 75 years
People
36
Run by
China Medical University, China
See details and how to joinNCT07373964
No phaseTaking people
A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery
Where
Beijing
Age
65 years and over
People
174
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT06674252
No phaseTaking people
Research on Early Screening and Diagnosis of Pulmonary Nodules Based on Novel Non-invasive Technologies.
Where
Beijing
Age
18 years and over
People
1,800
Run by
Chen KeZhong
See details and how to joinNCT07370077
No phaseNot yet taking people in China
18F-FAPI PET in Lung Cancer
Where
Hangzhou
Age
20 years to 85 years
People
120
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07370805
Phase 2Not yet taking people in China
Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study
Where
Tianjin
Age
18 years to 75 years
People
60
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07365410
Phase 1Taking people
First in Human Study of SIM0610 in Solid Tumors
Where
Chongqing, Harbin, Jinan, Shanghai, Shenyang
Age
18 years and over
People
260
Run by
Jiangsu Simcere Pharmaceutical Co., Ltd.
See details and how to joinNCT07348211